These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

168 related items for PubMed ID: 9448048

  • 21. Erythropoietin activates Raf1 by an Shc-independent pathway in CTLL-EPO-R cells.
    Barber DL, Corless CN, Xia K, Roberts TM, D'Andrea AD.
    Blood; 1997 Jan 01; 89(1):55-64. PubMed ID: 8978277
    [Abstract] [Full Text] [Related]

  • 22. Molecular targets of CD45 in B cell antigen receptor signal transduction.
    Pao LI, Bedzyk WD, Persin C, Cambier JC.
    J Immunol; 1997 Feb 01; 158(3):1116-24. PubMed ID: 9013950
    [Abstract] [Full Text] [Related]

  • 23. Gastrin induces tyrosine phosphorylation of Shc proteins and their association with the Grb2/Sos complex.
    Seva C, Kowalski-Chauvel A, Blanchet JS, Vaysse N, Pradayrol L.
    FEBS Lett; 1996 Jan 02; 378(1):74-8. PubMed ID: 8549807
    [Abstract] [Full Text] [Related]

  • 24. The 66-kDa Shc isoform is a negative regulator of the epidermal growth factor-stimulated mitogen-activated protein kinase pathway.
    Okada S, Kao AW, Ceresa BP, Blaikie P, Margolis B, Pessin JE.
    J Biol Chem; 1997 Oct 31; 272(44):28042-9. PubMed ID: 9346957
    [Abstract] [Full Text] [Related]

  • 25. Mechanism of mitogenic effect of fluoride on fetal rat osteoblastic cells: evidence for Shc, Grb2 and P-CREB-dependent pathways.
    Chae HJ, Chae SW, Kang JS, Kim DE, Kim HR.
    Res Commun Mol Pathol Pharmacol; 1999 Oct 31; 105(3):185-99. PubMed ID: 10954125
    [Abstract] [Full Text] [Related]

  • 26. The heterotrimeric G q protein-coupled angiotensin II receptor activates p21 ras via the tyrosine kinase-Shc-Grb2-Sos pathway in cardiac myocytes.
    Sadoshima J, Izumo S.
    EMBO J; 1996 Feb 15; 15(4):775-87. PubMed ID: 8631299
    [Abstract] [Full Text] [Related]

  • 27. N-Shc: a neural-specific adapter molecule that mediates signaling from neurotrophin/Trk to Ras/MAPK pathway.
    Nakamura T, Sanokawa R, Sasaki Y, Ayusawa D, Oishi M, Mori N.
    Oncogene; 1996 Sep 19; 13(6):1111-21. PubMed ID: 8808684
    [Abstract] [Full Text] [Related]

  • 28. Comparison of the insulin and insulin-like growth factor 1 mitogenic intracellular signaling pathways.
    Sasaoka T, Ishiki M, Sawa T, Ishihara H, Takata Y, Imamura T, Usui I, Olefsky JM, Kobayashi M.
    Endocrinology; 1996 Oct 19; 137(10):4427-34. PubMed ID: 8828504
    [Abstract] [Full Text] [Related]

  • 29. B cell antigen receptor cross-linking induces tyrosine phosphorylation and membrane translocation of a multimeric Shc complex that is augmented by CD19 co-ligation.
    Lankester AC, van Schijndel GM, Rood PM, Verhoeven AJ, van Lier RA.
    Eur J Immunol; 1994 Nov 19; 24(11):2818-25. PubMed ID: 7525306
    [Abstract] [Full Text] [Related]

  • 30. Insulin induces tyrosine phosphorylation of Shc and stimulates Shc/GRB2 association in insulin-sensitive tissues of the intact rat.
    Páez-Espinosa V, Carvalho CR, Alvarez-Rojas F, Janeri L, Velloso LA, Boschero AC, Saad MJ.
    Endocrine; 1998 Apr 19; 8(2):193-200. PubMed ID: 9704577
    [Abstract] [Full Text] [Related]

  • 31. Formation of Shc-Grb2 complexes is necessary to induce neoplastic transformation by overexpression of Shc proteins.
    Salcini AE, McGlade J, Pelicci G, Nicoletti I, Pawson T, Pelicci PG.
    Oncogene; 1994 Oct 19; 9(10):2827-36. PubMed ID: 8084588
    [Abstract] [Full Text] [Related]

  • 32. Src homology 2 protein tyrosine phosphatase (SHPTP2)/Src homology 2 phosphatase 2 (SHP2) tyrosine phosphatase is a positive regulator of the interleukin 5 receptor signal transduction pathways leading to the prolongation of eosinophil survival.
    Pazdrak K, Adachi T, Alam R.
    J Exp Med; 1997 Aug 18; 186(4):561-8. PubMed ID: 9254654
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Multiple hemopoietins, with the exception of interleukin-4, induce modification of Shc and mSos1, but not their translocation.
    Welham MJ, Duronio V, Leslie KB, Bowtell D, Schrader JW.
    J Biol Chem; 1994 Aug 19; 269(33):21165-76. PubMed ID: 8063737
    [Abstract] [Full Text] [Related]

  • 37. Tyrosine phosphorylation of Shc is not required for proliferation or viability signaling by granulocyte-macrophage colony-stimulating factor in hematopoietic cell lines.
    Durstin M, Inhorn RC, Griffin JD.
    J Immunol; 1996 Jul 15; 157(2):534-40. PubMed ID: 8752899
    [Abstract] [Full Text] [Related]

  • 38. Overexpression of Shc proteins potentiates the proliferative response to the granulocyte-macrophage colony-stimulating factor and recruitment of Grb2/SoS and Grb2/p140 complexes to the beta receptor subunit.
    Lanfrancone L, Pelicci G, Brizzi MF, Aronica MG, Casciari C, Giuli S, Pegoraro L, Pawson T, Pelicci PG, Arouica MG.
    Oncogene; 1995 Mar 02; 10(5):907-17. PubMed ID: 7898932
    [Abstract] [Full Text] [Related]

  • 39. The role of the Shc phosphotyrosine interaction/phosphotyrosine binding domain and tyrosine phosphorylation sites in polyoma middle T antigen-mediated cell transformation.
    Blaikie PA, Fournier E, Dilworth SM, Birnbaum D, Borg JP, Margolis B.
    J Biol Chem; 1997 Aug 15; 272(33):20671-7. PubMed ID: 9252386
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.